Skip to content
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Insider Trading
Home / Companies / MDGL MDG
MADRIGAL PHARMACEUTICALS, INC. (MDGL) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest MDGL Insider Trades
About MADRIGAL PHARMACEUTICALS, INC. (MDGL) Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Headquarters WEST CONSHOHOCKEN, PA
Employees 915
Listed 2007
Exchange XNAS https://www.madrigalpharma.com SEC filings for MDGL on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 11 3,164 $1.71M Grant or award 16 12,570 Option exercise 2 100,000
MDGL Insider Transactions (Form 4) 114 58 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 17, 2026 SK Shannon T. Kelley - Officer Open-market sale Common Stock 664
Recent MDGL Form 8-K Filings 5
Recent MDGL Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 20, 2026 Shannon Kelley Officer 664 $337K View on EDGAR Jul 20, 2026 - -
MDGL Insider Trading - FAQ
What is the latest insider trade for MDGL? MADRIGAL PHARMACEUTICALS, INC. (MDGL) had 9 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for MDGL runs to 58 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying MDGL stock? No insider purchases of MDGL were filed in the last 90 days. 26 purchases are on record for this company.
How many insiders are selling MDGL stock? 11 insider sales of MDGL were filed in the last 90 days, totaling $1.71M.
Where can I see MDGL SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks MDGL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow MDGL insider buys? Create a free InsiderAlpha account and press Watch on this page to add MDGL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track MDGL insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $76K
Market cap $12.33B
P/E ratio -
Dividend yield -
Average volume 357.1K
52 week high $615.00
52 week low $393.61
Today's high $542.16
Today's low $528.29
Open $539.38
Volume 268.7K
Previous close $543.69
Shares outstanding 23.10M Market cap
$12.33B
915 employees
MDGL Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 11 sales totaling $1.71M.
Most-Active MDGL Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 15, 2026 JR John C. Reed - Director Grant or award Common Stock 647 $0.00 -
Aug 15, 2026 JR John C. Reed - Director Grant or award Stock Option (Right to Buy) 1,078 $0.00 -
Jul 17, 2026 WS William John Sibold - Officer Option exercise Performance Restricted Stock Units 50,000 $0.00 -
Jun 17, 2026 RT Rebecca Taub - Director Grant or award Stock Option (Right to Buy) 766 $0.00 -
Jun 17, 2026 RT Rebecca Taub - Director Grant or award Common Stock 454 $0.00 -
Jun 17, 2026 RL Richard S. Levy - Director Grant or award Stock Option (Right to Buy) 766 $0.00 -
Jun 17, 2026 RL Richard S. Levy - Director Grant or award Common Stock 454 $0.00 -
Jun 17, 2026 JF Jacqualyn A. Fouse - Director Grant or award Stock Option (Right to Buy) 766 $0.00 -
Jun 17, 2026 JD James M. Daly - Director Grant or award Common Stock 454 $0.00 -
Jun 17, 2026 JD James M. Daly - Director Grant or award Stock Option (Right to Buy) 766 $0.00 -
Jun 17, 2026 DB Daniel J. Brennan - Director Grant or award Stock Option (Right to Buy) 681 $0.00 -
Jun 1, 2026 DS David Soergel - Officer Open-market sale Common Stock 1,042 $495.74 $517K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 40 $506.68 $20K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 320 $508.24 $163K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 151 $510.36 $77K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 610 $511.40 $312K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 439 $512.50 $225K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 40 $512.97 $21K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 343 $514.67 $177K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 657 $515.92 $339K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 723 $516.87 $374K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 1,497 $517.59 $775K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 782 $518.76 $406K
May 22, 2026 RL Richard S. Levy - Director Open-market sale Common Stock 80 $519.98 $42K
May 18, 2026 DS David Soergel - Officer Open-market sale Common Stock 844 $515.90 $435K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 420 $426.86 $179K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 80 $427.85 $34K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 160 $429.00 $69K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 40 $429.58 $17K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 120 $430.90 $52K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 116 $432.56 $50K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 160 $434.20 $69K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 80 $435.32 $35K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 80 $436.69 $35K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 40 $437.65 $18K
Mar 4, 2026 MD Mardi Dier - Officer Grant or award Stock Option (Right to Buy) 6,519 $0.00 -
Mar 4, 2026 MD Mardi Dier - Officer Grant or award Common Stock 5,215 $0.00 -
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 646 $431.94 $279K
Mar 6, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 40 $425.08 $17K
Mar 4, 2026 WS William John Sibold - Officer Grant or award Stock Option (Right to Buy) 18,743 $0.00 -
Mar 4, 2026 SK Shannon T. Kelley - Officer Grant or award Stock Option (Right to Buy) 5,022 $0.00 -
Mar 4, 2026 CH Carole Huntsman - Officer Grant or award Common Stock 3,989 $0.00 -
Mar 6, 2026 CH Carole Huntsman - Officer Open-market sale Common Stock 419 $431.94 $181K
Mar 4, 2026 CH Carole Huntsman - Officer Grant or award Stock Option (Right to Buy) 4,986 $0.00 -
Mar 6, 2026 RT Rebecca Taub - Director Open-market sale Common Stock 491 $431.94 $212K
Mar 4, 2026 DS David Soergel - Officer Grant or award Common Stock 4,374 $0.00 -
Mar 4, 2026 DS David Soergel - Officer Grant or award Stock Option (Right to Buy) 5,467 $0.00 -
Mar 2, 2026 MD Mardi Dier - Officer Open-market sale Common Stock 1,183 $427.21 $505K
Feb 23, 2026 RL Richard S. Levy - Director Option exercise Common Stock 2,500 $7.36 $18K
Feb 23, 2026 RL Richard S. Levy - Director Option exercise Stock Option (Right to Buy) 2,500 $0.00 -
Jan 26, 2026 RL Richard S. Levy - Director Option exercise Common Stock 4,000 $16.46 $66K
Jan 26, 2026 RL Richard S. Levy - Director Option exercise Stock Option (Right to Buy) 4,000 $0.00 -
Jan 26, 2026 CH Carole Huntsman - Officer Open-market sale Common Stock 340 $492.42 $167K
Jan 26, 2026 CH Carole Huntsman - Officer Open-market sale Common Stock 570 $494.59 $282K
Jan 26, 2026 RT Rebecca Taub - Director Open-market sale Common Stock 647 $492.42 $319K
Jan 20, 2026 RT Rebecca Taub - Director Open-market sale Common Stock 2,238 $490.77 $1.10M
Jan 15, 2026 RT Rita Thakkar - Officer Grant or award Common Stock 2,398 $0.00 -
Jan 15, 2026 RT Rita Thakkar - Officer Grant or award Stock Option (Right to Buy) 1,826 $0.00 -
Dec 3, 2025 WS William John Sibold - Officer Option exercise Performance Restricted Stock Units 50,000 - -
Dec 2, 2025 MD Mardi Dier - Officer Option exercise Common Stock 4,173 $251.63 $1.05M
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 320 $570.39 $183K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 410 $571.99 $235K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 354 $573.02 $203K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 717 $574.00 $412K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 120 $574.95 $69K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 240 $576.15 $138K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 320 $577.81 $185K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 258 $578.83 $149K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 480 $579.85 $278K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 240 $585.44 $141K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 240 $587.85 $141K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 160 $589.65 $94K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 160 $590.37 $94K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 74 $595.20 $44K
Dec 2, 2025 MD Mardi Dier - Officer Open-market sale Common Stock 80 $596.19 $48K
Dec 2, 2025 MD Mardi Dier - Officer Option exercise Stock Option (Right to Buy) 4,173 $0.00 -
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 120 $548.71 $66K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 40 $549.34 $22K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 200 $552.38 $110K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 40 $553.23 $22K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 120 $556.04 $67K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 200 $559.60 $112K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 80 $560.62 $45K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 40 $563.21 $23K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 80 $564.57 $45K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 894 $550.97 $493K
Nov 21, 2025 CH Carole Huntsman - Officer Open-market sale Common Stock 144 $547.27 $79K
$MGTX
MeiraGTx Holdings plc
$IONS
IONIS PHARMACEUTICALS INC
